Cargando…
In silico analysis reveals the co-existence of CRISPR-Cas type I-F1 and type I-F2 systems and its association with restricted phage invasion in Acinetobacter baumannii
INTRODUCTION: Acinetobacter baumannii, an opportunistic pathogen, rapidly acquires antibiotic resistance, thus compelling researchers to develop alternative treatments at utmost priority. Phage-based therapies are of appreciable benefit; however, CRISPR-Cas systems are a major constraint in this app...
Autores principales: | Yadav, Gulshan, Singh, Ruchi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428484/ https://www.ncbi.nlm.nih.gov/pubmed/36060733 http://dx.doi.org/10.3389/fmicb.2022.909886 |
Ejemplares similares
-
Type I-F CRISPR–Cas provides protection from DNA, but not RNA phages
por: Buyukyoruk, Murat, et al.
Publicado: (2019) -
Phage derived lytic peptides, a secret weapon against Acinetobacter baumannii—An in silico approach
por: Nandi, Abhishek, et al.
Publicado: (2022) -
A pyrF-Based Efficient Genetic Manipulation Platform in Acinetobacter baumannii To Explore the Vital DNA Components of Adaptive Immunity for I-F CRISPR-Cas
por: Wu, Shuqi, et al.
Publicado: (2022) -
CRISPR-cas Subtype I-Fb in Acinetobacter baumannii: Evolution and Utilization for Strain Subtyping
por: Karah, Nabil, et al.
Publicado: (2015) -
CRISPR-Cas in Acinetobacter baumannii Contributes to Antibiotic Susceptibility by Targeting Endogenous AbaI
por: Wang, Yuhang, et al.
Publicado: (2022)